- Fund Type: Fund of Funds
- Objective: Eq Directional-Long/Short Eq
- Asset Class: Alternative
- Geographic Focus: Brazil
Manager Advis Equity Hedge Fundo de Investimento em Cotas de Fundo de Investimen
+ Add to WatchlistMAEHICF:BZ
114.34 BRL 0.08 0.07%As of 00:59:30 ET on 05/21/2013.
Snapshot for Manager Advis Equity Hedge Fundo de Investimento em Cotas de Fundo de Investimen (MAEHICF)
| Year To Date: | +3.52% | 3-Month: | +2.31% | 3-Year: | - | 52-Week Range: | 108.87 - 115.33 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.09% | 1-Year: | +2.56% | 5-Year: | - | Beta vs BZACCETP: | 2.02 |
Fund Profile & Information for MAEHICF
Manager Advis Equity Hedge FIC FI Multimercado is an open-end fund of funds incorporated in Brazil. The Fund's objective is capital appreciation. The Fund will invest at least 95% of its assets in all types of other funds by adopting a long and short strategy to create a directional exposure.
| Inception Date: | 08-10-2011 | Telephone: | 55-11-3175-7491 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.safraasset.com.br/ | ||
Fundamentals for MAEHICF
| NAV | (on 2013-05-21) 114.34 |
|---|---|
| Assets (M) | (on 2013-05-21) 13.84 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for MAEHICF
No dividends reported
Fees & Expenses for MAEHICF
| Front Load | 0.00 |
|---|---|
| Back Load | 5.00 |
| Current Mgmt Fee | 2.50 |
| Redemption Fee | 5.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for MAEHICF
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Advis Equity Hedge S FIC FI Mu | 8,281,214 | 8,470,987 | 58.894% |
| Advis Equity Hedge FIC FI Mult | 4,373,368 | 5,906,680 | 41.066% |
| Safra Soberano Institucional F | 99 | 8,463 | 0.059% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page